Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction a study across therapeutic eras

Circulation: Heart Failure

Volumn 4, Issue 4, 2011, Pages 396-403

  Cubbon, Richard M ^a   Gale, Christopher P ^a,l   Kearney, Lorraine C ^a   Schechter, Clyde B ^b   Brooksby, W Paul ^c   Nolan, Jim ^d   Fox, Keith A A ^e   Rajwani, Adil ^a   Baig, Wazir ^f   Groves, David ^g   Barlow, Pauline ^g   Fisher, Anthony C ^h   Batin, Phillip D ^c   Kahn, Matthew B ^a   Zaman, Azfar G ⁱ   Shah, Ajay M ^j   Byrne, Jon A ^j   Lindsay, Steven J ^k   Sapsford, Robert J ^f   Wheatcroft, Stephen B ^a   Witte, Klaus K ^a   Kearney, Mark T ^a,m   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^g ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ NEWCASTLE UNIVERSITY   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k BRADFORD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^l YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^m Chapel Allerton Hospital   (United Kingdom)

more..

Author keywords

Chronic heart failure; Morbidity; Mortality

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAMIPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRODE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT DISPERSION; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; COMPARATIVE STUDY; DEFIBRILLATOR; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL RATE; UNITED KINGDOM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEART FAILURE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80052791290     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.959882     Document Type: Article

References (42)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119: e391-e479.
2. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin. 2001;19:547-555. (Pubitemid 33035501)
3. Heart Disease and Stroke Statistics. http://www.americanheart.org. Accessed June 30, 2010.
4. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325: 303-310.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp- Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
6. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352: 1539-1549. (Pubitemid 40517094)
7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-2150.
8. Clark RA, Inglis SC, McAlister FA, Cleland JGF, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ. 2007; 334:942.
9. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397-1402.. (Pubitemid 35239711)
10. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344-350. (Pubitemid 38944258)
11. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JWT, Capewell S, McMurray JJV. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009; 119:515-523.
12. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden. Eur Heart J. 2004;25:300-307.
13. Shafazand M, Schaufelberger M, Lappas G, Swedberg K, Rosengren A. Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry. Eur Heart J. 2009;30:671-678
14. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202... (Pubitemid 36068707)
15. Lenzen MJ, Boersma E, Scholte op Reimer WJM, Balk AHMM, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JGF. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005;26:2706-2713. (Pubitemid 41748284)
16. Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, Eckberg DL, Zaman AG, Williams S, Neilson JMM, Nolan J. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40:1801-1808. (Pubitemid 35341959)
17. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM, Fox KAA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Circulation. 1998;98:1510-1516. (Pubitemid 28481667)
18. Brooksby P, Batin PD, Nolan J, Lindsay SJ, Andrews R, Mullen M, Baig W, Flapan AD, Prescott RJ, Neilson JMM, Cowley AJ, Fox KAA. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure: the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART). Eur Heart J. 1999;20: 1335-1341. (Pubitemid 29429720)
19. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet. 1994;343: 327-329. (Pubitemid 24043180)
20. Bierig SM, Ehler D, Knoll ML, Waggoner AD. American Society of Echocardiography Minimum Standards for the Cardiac Sonographer: a position paper. J Am Soc Echocardiogr. 2006;19:471-474.
21. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 39:920-929.
22. Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
23. MERIT Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
24. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The Effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999; 341:709-717. (Pubitemid 29407370)
25. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-1321. (Pubitemid 36384098)
26. Carson P, Anand I, O'Connor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, Ghali J, Barnet JH, Feldman AM, Bristow MR. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial. J Am Coll Cardiol. 2005;46:2329-2334. (Pubitemid 41785506)
27. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, Feldman AM, Galle E, Ecklund F. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation. 2006;114:2766-2772. (Pubitemid 46018278)
28. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF Trial. J Card Fail. 2008;14:670-675.
29. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol. 2005;46:2183-2192. (Pubitemid 41785483)
30. Iacoviello M, Forleo C, Guida P, Romito R, Sorgente A, Sorrentino S, Catucci S, Mastropasqua F, Pitzalis M. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2007;50:225-231. (Pubitemid 47033970)
31. Yamada T, Shimonagata T, Misaki N, Asai M, Makino N, Kioka H, Tamaki S, Fukunami M. Usefulness of spatial dispersion of QRS duration in predicting mortality in patients with mild to moderate chronic heart failure. Am J Cardiol. 2004;94:960-963. (Pubitemid 39349570)
32. Hofmann M, Bauer R, Handrock R, Weidinger G, Goedel-Meinen L. Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT. J Card Fail. 2005;11: 523-528. (Pubitemid 41399892)
33. Pai RG, Padmanabhan S. Biological correlates of QT interval and QT dispersion in 2,265 patients with left ventricular ejection fraction [le]40%. J Electrocardiol. 2002;35:223-226. (Pubitemid 34787340)
34. Gang Y, Ono T, Hnatkova K, Hashimoto K, Camm A, Pitt B, Poole- Wilson PA, Malik M. QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II Substudy. Pacing Clin Electrophysiol. 2003;26:394-400. (Pubitemid 36399180)
35. Ranade V, Molnar J, Khokher T, Agarwal A, Mosnaim A, Somberg J. Effect of Angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther. 1999;6:257-261. (Pubitemid 29445367)
36. Rocha R, Silva G, Perin E, Gerk A, Gouvea E, Santos VAS, Filho FM, de Albuquerque DC. Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly? Tex Heart Inst J. 2003;30:176-179. (Pubitemid 37046584)
37. Farquharson CAJ, Struthers AD. Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extrasystoles but does not change endothelial function or heart rate variability in chronic heart failure. Heart. 2002;88:475-480. (Pubitemid 35221958)
38. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1989;13:311-315. (Pubitemid 19055651)
39. Cohn JN. Structural basis for heart failure: ventricular remodeling and its pharmacological inhibition. Circulation. 1995;91:2504-2507.
40. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997;336:1350-1355. (Pubitemid 27208618)
41. Morrison A. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol. 1982;11:261-267. (Pubitemid 12019150)
42. Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SMC, Sutton GC, McDonagh TA, Cowie MR. Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail. 2008;10:1108-1116.